PMID: 9546582Apr 18, 1998Paper

Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin

Molecular and Cellular Biochemistry
L R Chaudhary, L V Avioli

Abstract

The mitogen-activated protein (MAP) kinases (p44mapk and p42mapk), also known as extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2), are activated in response to a variety of extracellular signals, including growth factors, hormones and, neurotransmitters. We have investigated MAP kinase signal transduction pathways in normal human osteoblastic cells. Normal human bone marrow stromal (HBMS), osteoblastic (HOB), and human (TE85, MG-63, SaOS-2), rat (ROS 17/2.8, UMR-106) and mouse (MC3T3-E1) osteoblastic cell lines contained immunodetectable p44mapk/ERK1 and p42mapk/ERK2. MAP kinase activity was measured by 'in-gel' assay using myelin basic protein as the substrate. Mainly ERK2 was rapidly activated (within 10 min) by bFGF, IGF-I and PDGF-BB in normal HOB, HBMS and human osteosarcoma cells, whereas both ERK1 and ERK2 were activated by growth factors in rat osteoblast-like cell lines, ROS 17/2.8 and UMR-106. The ERK1 activation was greater than the ERK2 in ROS 17/2.8 cells. Furthermore, ERK2 was also activated by bFGF and PDGF-BB in the mouse osteoblastic cell line, MC3T3-E1. This is the first demonstration of inter-species differences in the activation of MAP kinases in osteoblastic cells. Cyclic AMP derivatives or cA...Continue Reading

Citations

Apr 14, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Tanuka DattaNabanita S Datta
Apr 1, 2000·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·M Garcia-RamirezL Audi
Aug 17, 1999·The Journal of Clinical Investigation·J M Hock
Oct 18, 2000·Journal of Biomedical Materials Research·E A CowlesG A Gronowicz
Jan 29, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sunil WadhwaCarol C Pilbeam
Apr 2, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Ming Zhao ChengLance E Lanyon
Oct 31, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Shilpa ChoudharyCarol C Pilbeam
Sep 26, 2006·Canadian Journal of Physiology and Pharmacology·D A Barrio, S B Etcheverry
Nov 17, 2006·American Journal of Physiology. Renal Physiology·W Bruce SneddonPeter A Friedman
Aug 3, 2001·Blood Cells, Molecules & Diseases·M W Long
Feb 12, 2000·Prostaglandins, Leukotrienes, and Essential Fatty Acids·L C CarpioR Dziak
Sep 11, 2002·Biochemical and Biophysical Research Communications·Sunil WadhwaCarol Pilbeam
May 24, 2003·Biochemical and Biophysical Research Communications·Edelgard Kaiser, Srinivasan Chandrasekhar
Jan 20, 2004·Seminars in Nephrology·Keith A HruskaKameswaran Surendran
Dec 13, 2005·Kidney International. Supplement·Keith A HruskaRichard J Lund
Aug 10, 2010·Biomacromolecules·Mara L MacdonaldPaula T Hammond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.